Hoover IP² Working Group Advisory Board
Roy Waldron is the Chief Intellectual Property Counsel, Senior Vice President & Associate General Counsel at Pfizer Inc., one of the largest pharmaceutical companies in the world with R&D focusing on Oncology, Vaccines, Inflammation & Immunology, Rare Diseases, Neuroscience, Pain and Metabolic Diseases. Roy leads the team that procures and protects Pfizer patents and trademarks around the world; and works closely with Pfizer Worldwide Research & Development, the Pfizer Business Units and their Business Development groups. He represents Pfizer on the committees of various industry organizations including IFPMA (Chair of International IP & Trade Committee), PhRMA (International IP & Policy Working Group), Intellectual Property Owners Association (Executive Committee; Board of Directors, Amicus Committee) and INTERPAT (Executive Committee). Prior to Pfizer, Roy was in private practice at White & Case LLP and Fish & Neave. He has a JD from New York University Law School, a PhD from Yale (physical-organic chemistry) and a BA (chemistry) from Dartmouth College. He was also a DAAD Scholar at the Albrecht-Ludwigs University in Freiburg Germany and a JSPS Post-Doctoral Fellow at Kyoto University Japan.
Updated February 9, 2015